Infinity Bio

Infinity Bio

Infinity Bio, Inc. is an antibody profiling company and developer of the up coming novel molecular display technology that employs self-assembling barcoded proteins and peptides.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor investor

€0.0

round
*

$8.0m

Series A
Total Funding000k
Notes (0)
More about Infinity Bio
Made with AI
Edit

Infinity Bio is a biotechnology company that has developed a proprietary platform for antibody reactome profiling, enabling the analysis of immune responses at a large scale. The company provides services to gain insights into the interactions between antibodies and antigens, particularly in the context of viral exposures and autoimmune diseases.

Its business model revolves around offering specialized services and analytics to researchers, pharmaceutical companies, and other entities in the life sciences sector. Infinity Bio generates revenue by providing access to its advanced technology and expertise in interpreting the complex data derived from antibody profiling. The company's key offerings include the VirSIGHT™ profiler, which focuses on the human virome, and the HuSIGHT™ profiler, which is geared towards understanding autoimmune responses. Additionally, Infinity Bio offers the creation of custom antigen libraries to meet specific research needs.

Keywords: antibody profiling, reactome, immune response, biotechnology, virome, autoimmune, antigen libraries, diagnostics, life sciences, immunology

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo